Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1993 Nov;94(2):306–312. doi: 10.1111/j.1365-2249.1993.tb03448.x

Factors influencing the occurrence of active cytomegalovirus (CMV) infections after organ transplantation.

G J Boland 1, R J Hene 1, C Ververs 1, M A de Haan 1, G C de Gast 1
PMCID: PMC1534232  PMID: 8222321

Abstract

In this study, several factors influencing the occurrence of active CMV infection after organ transplantation (Tx) are analysed. For this purpose, 105 heart, kidney and lung transplant recipients who were CMV-positive or had a CMV-positive donor, were closely monitored for active CMV infection by antigenaemia, cultures, CMV serology and lymphocyte proliferation (LP) to CMV. Univariate and multivariate regression analysis were performed. As pretransplant risk factors the HLA-type and numbers of HLA mismatches between recipients and their donors, and the CMV serology of the recipient and donor were analysed. A new finding was that recipients of donors positive for HLA-B7 were especially at risk for developing active CMV infection (P = 0.03) and CMV disease (P = 0.03). This was not due to increased rejection treatment in these patients. Post-transplant risk factors for development of active CMV infection were absence of detectable cellular immunity to CMV (lymphocyte proliferation) after Tx (P < 0.01) and rejection treatment with OKT3 or ATG (P = 0.05). High levels of IgG anti-CMV did not prevent occurrence of active CMV infection or CMV disease in the CMV+ recipients.

Full text

PDF
306

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Betts R. F., Freeman R. B., Douglas R. G., Jr, Talley T. E., Rundell B. Transmission of cytomegalovirus infection with renal allograft. Kidney Int. 1975 Dec;8(6):385–392. doi: 10.1038/ki.1975.131. [DOI] [PubMed] [Google Scholar]
  2. Bia M. J., Andiman W., Gaudio K., Kliger A., Siegel N., Smith D., Flye W. Effect of treatment with cyclosporine versus azathioprine on incidence and severity of cytomegalovirus infection posttransplantation. Transplantation. 1985 Dec;40(6):610–614. doi: 10.1097/00007890-198512000-00007. [DOI] [PubMed] [Google Scholar]
  3. Blancho G., Josien R., Douillard D., Bignon J. D., Cesbron A., Soulillou J. P. The influence of HLA A-B-DR matching on cytomegalovirus disease after renal transplantation. Evidence that HLA-DR7-matched recipients are more susceptible to cytomegalovirus disease. Transplantation. 1992 Nov;54(5):871–874. doi: 10.1097/00007890-199211000-00020. [DOI] [PubMed] [Google Scholar]
  4. Boeckh M., Bowden R. A., Goodrich J. M., Pettinger M., Meyers J. D. Cytomegalovirus antigen detection in peripheral blood leukocytes after allogeneic marrow transplantation. Blood. 1992 Sep 1;80(5):1358–1364. [PubMed] [Google Scholar]
  5. Boland G. J., de Gast G. C., Hené R. J., Jambroes G., Donckerwolcke R., The T. H., Mudde G. C. Early detection of active cytomegalovirus (CMV) infection after heart and kidney transplantation by testing for immediate early antigenemia and influence of cellular immunity on the occurrence of CMV infection. J Clin Microbiol. 1990 Sep;28(9):2069–2075. doi: 10.1128/jcm.28.9.2069-2075.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chou S. W. Neutralizing antibody responses to reinfecting strains of cytomegalovirus in transplant recipients. J Infect Dis. 1989 Jul;160(1):16–21. doi: 10.1093/infdis/160.1.16. [DOI] [PubMed] [Google Scholar]
  7. Chou S. W., Norman D. J. The influence of donor factors other than serologic status on transmission of cytomegalovirus to transplant recipients. Transplantation. 1988 Jul;46(1):89–93. doi: 10.1097/00007890-198807000-00016. [DOI] [PubMed] [Google Scholar]
  8. Chou S. W. Reactivation and recombination of multiple cytomegalovirus strains from individual organ donors. J Infect Dis. 1989 Jul;160(1):11–15. doi: 10.1093/infdis/160.1.11. [DOI] [PubMed] [Google Scholar]
  9. Enssle K. H., Wagner H., Fleischer B. Human mumps virus-specific cytotoxic T lymphocytes: quantitative analysis of HLA restriction. Hum Immunol. 1987 Feb;18(2):135–149. doi: 10.1016/0198-8859(87)90011-5. [DOI] [PubMed] [Google Scholar]
  10. Fiala M., Payne J. E., Berne T. V., Moore T. C., Henle W., Montgomerie J. Z., Chatterjee S. N., Guze L. B. Epidemiology of cytomegalovirus infection after transplantation and immunosuppression. J Infect Dis. 1975 Oct;132(4):421–433. doi: 10.1093/infdis/132.4.421. [DOI] [PubMed] [Google Scholar]
  11. Grundy J. E., Lui S. F., Super M., Berry N. J., Sweny P., Fernando O. N., Moorhead J., Griffiths P. D. Symptomatic cytomegalovirus infection in seropositive kidney recipients: reinfection with donor virus rather than reactivation of recipient virus. Lancet. 1988 Jul 16;2(8603):132–135. doi: 10.1016/s0140-6736(88)90685-x. [DOI] [PubMed] [Google Scholar]
  12. Ho M., Suwansirikul S., Dowling J. N., Youngblood L. A., Armstrong J. A. The transplanted kidney as a source of cytomegalovirus infection. N Engl J Med. 1975 Nov 27;293(22):1109–1112. doi: 10.1056/NEJM197511272932201. [DOI] [PubMed] [Google Scholar]
  13. Kernan N. A., Flomenberg N., Dupont B., O'Reilly R. J. Graft rejection in recipients of T-cell-depleted HLA-nonidentical marrow transplants for leukemia. Identification of host-derived antidonor allocytotoxic T lymphocytes. Transplantation. 1987 Jun;43(6):842–847. [PubMed] [Google Scholar]
  14. Kraat Y. J., Christiaans M. H., Nieman F. H., van den Berg-Loonen P. M., van Hooff J. P., Bruggeman C. A. Increased frequency of CMV infection in HLA-DR7 matched renal allograft recipients. Lancet. 1993 Feb 20;341(8843):494–495. doi: 10.1016/0140-6736(93)90248-f. [DOI] [PubMed] [Google Scholar]
  15. Mentzer S. J., Smith B. R., Barbosa J. A., Crimmins M. A., Herrmann S. H., Burakoff S. J. CTL adhesion and antigen recognition are discrete steps in the human CTL-target cell interaction. J Immunol. 1987 Mar 1;138(5):1325–1330. [PubMed] [Google Scholar]
  16. Pass R. F., Griffiths P. D., August A. M. Antibody response to cytomegalovirus after renal transplantation: comparison of patients with primary and recurrent infections. J Infect Dis. 1983 Jan;147(1):40–46. doi: 10.1093/infdis/147.1.40. [DOI] [PubMed] [Google Scholar]
  17. Roenhorst H. W., Middeldorp J. M., Beelen J. M., Schirm J., Tegzess A. M., The T. H. Maintenance of cytomegalovirus (CMV) latency and host immune responses of long term renal allograft survivors. I. Prolonged suppression of in vitro lymphocyte responses against CMV infected fibroblasts related to previous secondary CMV infection. Clin Exp Immunol. 1985 Mar;59(3):709–715. [PMC free article] [PubMed] [Google Scholar]
  18. Roenhorst H. W., Tegzess A. M., Beelen J. M., Middeldorp J. M., The T. H. HLA-DRw6 as a risk factor for active cytomegalovirus but not for herpes simplex virus infection after renal allograft transplantation. Br Med J (Clin Res Ed) 1985 Sep 7;291(6496):619–622. doi: 10.1136/bmj.291.6496.619. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Schrier R. D., Rice G. P., Oldstone M. B. Suppression of natural killer cell activity and T cell proliferation by fresh isolates of human cytomegalovirus. J Infect Dis. 1986 Jun;153(6):1084–1091. doi: 10.1093/infdis/153.6.1084. [DOI] [PubMed] [Google Scholar]
  20. Stern H., Hannington G., Booth J., Moncrieff D. An early marker of fetal infection after primary cytomegalovirus infection in pregnancy. Br Med J (Clin Res Ed) 1986 Mar 15;292(6522):718–720. doi: 10.1136/bmj.292.6522.718. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. The T. H., Klein G., Langenhuysen M. M. Antibody reactions to virus-specific early antigens (EA) in patients with cytomegalovirus (CMV) infection. Clin Exp Immunol. 1974 Jan;16(1):1-7,9-12. [PMC free article] [PubMed] [Google Scholar]
  22. Vlieger A. M., Boland G. J., Jiwa N. M., de Weger R. A., Willemze R., de Gast G. C., Falkenburg J. H. Cytomegalovirus antigenemia assay or PCR can be used to monitor ganciclovir treatment in bone marrow transplant recipients. Bone Marrow Transplant. 1992 Apr;9(4):247–253. [PubMed] [Google Scholar]
  23. Waltzer W. C., Arnold A. N., Anaise D., Hurley S., Raisbeck A., Egelandsdsdal B., Pullis C., Rapaport F. T. Impact of cytomegalovirus infection and HLA-matching on outcome of renal transplantation. Transplant Proc. 1987 Oct;19(5):4077–4080. [PubMed] [Google Scholar]
  24. Whelchel J. D., Pass R. F., Diethelm A. G., Whitley R. J., Alford C. A., Jr Effect of primary and recurrent cytomegalovirus infections upon graft and patient survival after renal transplantation. Transplantation. 1979 Dec;28(6):443–446. [PubMed] [Google Scholar]
  25. Wreghitt T. G., Hakim M., Gray J. J., Kucia S., Cory-Pearce R., Wallwork J., English T. A. A detailed study of cytomegalovirus infections in the first 160 heart and heart/lung transplant recipients at Papworth Hospital, Cambridge, England. Transplant Proc. 1987 Feb;19(1 Pt 3):2495–2496. [PubMed] [Google Scholar]
  26. van Rood J. J., van Leeuwen A., Ploem J. S. Simultaneous detection of two cell populations by two-colour fluorescence and application to the recognition of B-cell determinants. Nature. 1976 Aug 26;262(5571):795–797. doi: 10.1038/262795a0. [DOI] [PubMed] [Google Scholar]
  27. van Seventer G. A., Huis B., Melief C. J., Iványi P. Fine specificity of human HLA-B7-specific cytotoxic T-lymphocyte clones. I. Identification of HLA-B7 subtypes and histotopes of the HLA-B7 cross-reacting group. Hum Immunol. 1986 Aug;16(4):375–389. doi: 10.1016/0198-8859(86)90064-9. [DOI] [PubMed] [Google Scholar]
  28. van Son W. J., The T. H. Cytomegalovirus infection after organ transplantation: an update with special emphasis on renal transplantation. Transpl Int. 1989 Oct;2(3):147–164. doi: 10.1007/BF02414602. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES